Immunoclin (Immunoclin) Other Net Income (Loss) : $0.00 Mil (TTM As of Oct. 2014)

View and export this data going back to 2012. Start your Free Trial

What is Immunoclin Other Net Income (Loss)?

Immunoclin's Other Net Income (Loss) for the three months ended in Oct. 2014 was $0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Oct. 2014 was $0.00 Mil.

Immunoclin Other Net Income (Loss) Historical Data

The historical data trend for Immunoclin's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin Other Net Income (Loss) Chart

Immunoclin Annual Data

Trend

Feb12

Jan13

Jan14

Other Net Income (Loss)

Immunoclin Quarterly Data
	May11	Aug11	Nov11	Feb12	May12	Aug12	Nov12	Feb13	May13	Aug13	Nov13	Apr14	Jul14	Oct14
Other Net Income (Loss)	Get a 7-Day Free Trial									-	-	-	-	-

Immunoclin Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Oct. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Immunoclin Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Immunoclin's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunoclin (Immunoclin) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210

Website

http://www.immunoclin.com

Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines